First Header Logo Second Header Logo

William Petty

Concepts (140)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
14
2018
387
1.560
Why?
Carcinoma, Non-Small-Cell Lung
7
2018
93
1.140
Why?
Quinazolines
4
2013
31
0.910
Why?
Neoplasms, Vascular Tissue
1
2012
7
0.440
Why?
Knee Prosthesis
1
2012
14
0.440
Why?
Antineoplastic Agents
5
2018
547
0.440
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2012
22
0.430
Why?
Sarcoma
1
2012
56
0.420
Why?
Osteoarthritis, Knee
1
2012
80
0.410
Why?
Arthroplasty, Replacement, Knee
1
2012
84
0.400
Why?
Periodicals as Topic
1
2012
95
0.390
Why?
Gastrointestinal Neoplasms
1
2011
32
0.390
Why?
Angiotensin I
1
2012
262
0.370
Why?
Carcinoma
1
2011
87
0.370
Why?
Peptide Fragments
1
2012
423
0.340
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2018
401
0.310
Why?
Aged
14
2018
9528
0.250
Why?
Middle Aged
15
2018
10892
0.240
Why?
Radiosurgery
4
2017
322
0.240
Why?
Adenocarcinoma
3
2017
301
0.240
Why?
Brain Neoplasms
3
2017
587
0.230
Why?
Protein Kinase Inhibitors
3
2017
77
0.230
Why?
Humans
21
2018
29294
0.220
Why?
Gene Expression Profiling
3
2017
321
0.220
Why?
Cyclin D3
2
2013
4
0.220
Why?
Cyclin D1
2
2013
15
0.220
Why?
Disease-Free Survival
4
2017
281
0.210
Why?
Aged, 80 and over
8
2018
3729
0.210
Why?
Retrospective Studies
8
2018
3129
0.200
Why?
Adult
10
2018
8484
0.200
Why?
Male
15
2018
17896
0.190
Why?
Female
15
2018
18270
0.190
Why?
Treatment Outcome
5
2017
3116
0.190
Why?
Neoplasm Invasiveness
2
2017
189
0.180
Why?
Carboplatin
1
2018
40
0.160
Why?
Paclitaxel
1
2018
51
0.160
Why?
Nervous System Diseases
1
2018
37
0.160
Why?
Immunotherapy
1
2018
71
0.150
Why?
Neoplastic Cells, Circulating
1
2017
23
0.150
Why?
DNA, Neoplasm
1
2017
58
0.150
Why?
Fetal Proteins
1
2016
7
0.150
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2016
10
0.150
Why?
T-Box Domain Proteins
1
2016
12
0.150
Why?
Smoking
2
2017
440
0.140
Why?
Small Cell Lung Carcinoma
1
2016
14
0.140
Why?
Sulfides
1
2016
24
0.140
Why?
Caprylates
1
2016
25
0.140
Why?
Hospice Care
1
2016
13
0.140
Why?
Terminal Care
1
2016
19
0.140
Why?
Neoplasms
3
2018
620
0.140
Why?
Taxoids
2
2013
48
0.140
Why?
Drug Administration Schedule
2
2013
246
0.140
Why?
Palliative Care
1
2016
47
0.140
Why?
Mice
2
2012
2380
0.140
Why?
Cryopreservation
1
2016
53
0.130
Why?
Spermatogenesis
1
2016
45
0.130
Why?
Testis
1
2016
60
0.130
Why?
Neoplasm Metastasis
1
2016
199
0.130
Why?
Neoplasm Recurrence, Local
2
2016
337
0.130
Why?
Tomography Scanners, X-Ray Computed
1
2015
9
0.130
Why?
Lung
1
2016
235
0.130
Why?
Mutation
1
2017
469
0.120
Why?
Dapsone
1
2014
3
0.120
Why?
Mediastinal Neoplasms
1
2014
13
0.120
Why?
Anemia, Hemolytic
1
2014
6
0.120
Why?
Cell Proliferation
2
2016
574
0.120
Why?
Hydroxamic Acids
1
2014
17
0.120
Why?
Filgrastim
1
2013
4
0.120
Why?
Thorax
1
2014
27
0.120
Why?
Survival
1
2013
13
0.120
Why?
Radiotherapy, Conformal
2
2012
19
0.120
Why?
Granulocyte Colony-Stimulating Factor
1
2013
21
0.120
Why?
Academic Medical Centers
1
2015
150
0.120
Why?
Carcinoma, Small Cell
1
2013
21
0.120
Why?
Salvage Therapy
1
2014
118
0.120
Why?
Polyethylene Glycols
1
2013
66
0.120
Why?
Cisplatin
1
2013
69
0.120
Why?
Attitude of Health Personnel
1
2015
163
0.110
Why?
Recombinant Proteins
1
2013
249
0.110
Why?
Cementation
1
2012
1
0.110
Why?
Esophagitis
1
2012
5
0.110
Why?
Follow-Up Studies
3
2014
2117
0.110
Why?
Pregnancy Proteins
1
2012
10
0.110
Why?
Esophagus
1
2012
22
0.110
Why?
Prosthesis Design
1
2012
87
0.110
Why?
Glioblastoma
1
2014
143
0.110
Why?
Carcinoma, Squamous Cell
1
2013
142
0.110
Why?
Biomarkers, Pharmacological
1
2011
5
0.100
Why?
Cyclin E
1
2011
5
0.100
Why?
Health Knowledge, Attitudes, Practice
1
2015
327
0.100
Why?
Analysis of Variance
1
2012
454
0.100
Why?
NIH 3T3 Cells
1
2011
43
0.100
Why?
Drug Resistance, Neoplasm
1
2011
90
0.090
Why?
Animals
2
2012
7318
0.090
Why?
Immunohistochemistry
1
2011
520
0.090
Why?
Astrocytoma
1
2008
30
0.080
Why?
Time Factors
1
2012
2009
0.070
Why?
Survival Rate
3
2016
796
0.070
Why?
Neoplasm Staging
3
2014
437
0.070
Why?
Cell Line, Tumor
2
2016
683
0.060
Why?
Cohort Studies
2
2018
1697
0.050
Why?
Radiotherapy Dosage
2
2014
98
0.050
Why?
Combined Modality Therapy
2
2014
525
0.050
Why?
Prognosis
2
2014
1366
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, Neoplasm
1
2017
18
0.040
Why?
Genes, p53
1
2017
23
0.040
Why?
Genes, ras
1
2017
26
0.040
Why?
Sequence Analysis, DNA
1
2017
139
0.040
Why?
Topotecan
1
2016
15
0.040
Why?
MAP Kinase Signaling System
1
2016
57
0.040
Why?
Neoplastic Stem Cells
1
2017
90
0.040
Why?
Proportional Hazards Models
1
2018
710
0.040
Why?
Tissue Banks
1
2016
16
0.030
Why?
Neoplasm Proteins
1
2017
141
0.030
Why?
Geriatric Assessment
1
2018
356
0.030
Why?
Infertility, Male
1
2016
26
0.030
Why?
Survival Analysis
1
2017
440
0.030
Why?
Prevalence
1
2018
908
0.030
Why?
Patient Care Team
1
2016
124
0.030
Why?
Age Factors
1
2018
1115
0.030
Why?
Disease Progression
1
2017
572
0.030
Why?
Radiation Dosage
1
2015
72
0.030
Why?
Early Detection of Cancer
1
2015
75
0.030
Why?
Radiography
1
2015
354
0.030
Why?
Hospitalization
1
2016
418
0.030
Why?
Signal Transduction
1
2016
667
0.030
Why?
Tracheoesophageal Fistula
1
2012
4
0.030
Why?
Remission Induction
1
2012
78
0.030
Why?
Infant
1
2016
974
0.030
Why?
Treatment Failure
1
2012
159
0.030
Why?
Child, Preschool
1
2016
1170
0.030
Why?
Chemotherapy, Adjuvant
1
2012
163
0.030
Why?
Maximum Tolerated Dose
1
2010
56
0.020
Why?
Child
1
2016
2226
0.020
Why?
Imaging, Three-Dimensional
1
2010
130
0.020
Why?
Adolescent
1
2016
3267
0.020
Why?
United States
1
2016
3655
0.020
Why?
Clinical Trials as Topic
1
2008
299
0.020
Why?
Petty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (44)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_